Timmune Biotech Inc.   Report issue

For profit Phase 1 Phase 2
Founded: China (2015)

Organization Overview

First Clinical Trial
2018
NCT03497533
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Timmune Biotech Inc.